STOCK TITAN

Masimo Corporation - MASI STOCK NEWS

Welcome to our dedicated page for Masimo Corporation news (Ticker: MASI), a resource for investors and traders seeking the latest updates and insights on Masimo Corporation stock.

Masimo Corporation (NASDAQ: MASI) is a leading global medical technology company specializing in the development and manufacturing of innovative noninvasive patient monitoring technologies. For over 27 years, Masimo has been at the forefront of medical advancements, offering a wide array of sensors and devices that enhance patient care and safety. Their products are designed to provide healthcare professionals with critical information to improve clinical decision-making.

Masimo's core business is divided into two segments: healthcare and non-healthcare. The healthcare segment is the primary revenue generator, focusing on noninvasive patient monitoring technologies, hospital automation, connectivity solutions, and remote monitoring devices. Their clinically proven products are widely used in hospitals, emergency rooms, and clinical settings around the world.

The non-healthcare segment encompasses the consumer audio business, which includes the development, manufacturing, marketing, and licensing of premium and luxury audio sound products. This segment is known for its advanced audio integration technologies that appeal to audiophiles and general consumers alike.

Masimo's recent achievements include expanding their product portfolio with advanced remote monitoring solutions, partnering with leading healthcare organizations, and pioneering innovative technologies that address unsolvable medical challenges. Financially, the company is robust, showing consistent growth and a strong market presence.

Masimo’s dedication to improving lives is evident in their mission to save, extend, and enhance the quality of life across all demographics. Their innovative spirit attracts individuals who are passionate about making a significant impact in the medical field. As they continue to innovate, Masimo remains committed to providing top-tier products that meet the evolving needs of the healthcare industry.

Rhea-AI Summary

Masimo (NASDAQ: MASI) and Denon have launched the White PerL and PerL Pro earbuds, promising cutting-edge personalized audio. Featuring Masimo’s Adaptive Acoustic Technology (AAT), these earbuds tailor sound based on individual hearing profiles, enhancing depth, detail, and clarity. Denon's legacy of audio excellence combines with Masimo's innovation for a superior listening experience. The earbuds offer active noise cancellation, social mode, and, in the Pro model, spatial audio and adaptive noise cancellation. Available now, the Denon PerL is priced at $199, and the PerL Pro at $349.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.84%
Tags
none
-
Rhea-AI Summary

Masimo (NASDAQ: MASI) will present at the BofA Securities Health Care Conference on May 15, 2024. A live webcast will be available on their website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.75%
Tags
conferences
-
Rhea-AI Summary

Masimo reported strong financial results for the first quarter of 2024 with consolidated revenue at $492.8 million, including healthcare revenue of $339.6 million and non-healthcare revenue of $153.2 million. GAAP net income per diluted share was $0.35 and Non-GAAP net income per diluted share was $0.77. The company saw improvements in gross margins in healthcare and is increasing guidance for healthcare revenues and EPS for 2024. Masimo also announced plans to separate its consumer business.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.75%
Tags
Rhea-AI Summary

Masimo, a global leader in monitoring technologies, received FDA clearance for Stork™, an over-the-counter baby monitoring system for infants up to 18 months. The system provides continuous monitoring of oxygen saturation, pulse rate, and skin temperature without a prescription. It offers visual and audible alarms if readings fall outside preset ranges, utilizing advanced pulse oximetry technology. Stork is available at major retailers and online, with additional alarm features through a mobile app update. Stork features a sleek design, patented SET® sensor technology, and a camera with future AI-based features. It is FDA-cleared for OTC use, suitable for infants and neonates in home environments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.73%
Tags
-
Rhea-AI Summary
Masimo (NASDAQ: MASI) is set to report its first quarter 2024 financial results on May 7, 2024, after the market closes. The conference call to discuss the results will be hosted by Joe Kiani, Chairman and CEO, and Micah Young, CFO.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.96%
Tags
conferences earnings
-
Rhea-AI Summary
Masimo Founder and CEO Joe Kiani will discuss the impact of AI-based medical solutions on patient safety at the 6th Global Ministerial Summit on Patient Safety in Chile.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.05%
Tags
conferences AI
Rhea-AI Summary
Masimo confirms Politan Capital Management's intent to nominate board candidates, opposing the company's Chairman and CEO. Politan's claims of lack of information and access are refuted by Masimo, highlighting ongoing engagement and discussions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.38%
Tags
none
-
Rhea-AI Summary
Masimo (NASDAQ: MASI) plans to separate its consumer business, focusing on consumer audio and health products like the Stork baby monitor and Freedom smart watch. The separation aims to enhance healthcare business profitability and shareholder value. Joe Kiani will continue as Chairman and CEO, overseeing the transition.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.34%
Tags
management
-
Rhea-AI Summary
Masimo (NASDAQ: MASI) has been named one of Fast Company’s Most Innovative Companies in North America for 2024, highlighting its commitment to innovation in healthcare. The company's breakthrough technologies, including Opioid Halo™ and Stork™, have received FDA clearance in 2023. Masimo's dedication to improving patient care through cutting-edge solutions has earned it a place among the top 10 innovative organizations in the North America sector.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.45%
Tags
none
Rhea-AI Summary
Masimo (NASDAQ: MASI) and Bowers & Wilkins received six prestigious accolades at the iF DESIGN AWARDS 2024, showcasing their commitment to design excellence and innovation. With 11,000 submissions from 72 countries, Masimo's products like Stork™ and Bowers & Wilkins' headphones and car audio systems were recognized across different categories, highlighting their dedication to pushing design boundaries. The awards affirm Masimo's focus on delivering excellence in design and technology to enhance people's lives globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.47%
Tags
none

FAQ

What is the current stock price of Masimo Corporation (MASI)?

The current stock price of Masimo Corporation (MASI) is $169.52 as of December 20, 2024.

What is the market cap of Masimo Corporation (MASI)?

The market cap of Masimo Corporation (MASI) is approximately 9.1B.

What is Masimo Corporation's main business?

Masimo Corporation specializes in developing and manufacturing noninvasive patient monitoring technologies and premium audio products.

How long has Masimo Corporation been in operation?

Masimo has been operational for over 27 years, continually innovating in the medical technology field.

What are the key segments of Masimo's business?

Masimo operates in two key segments: healthcare, which includes patient monitoring technologies, and non-healthcare, which includes premium audio products.

What products does Masimo offer?

Masimo offers noninvasive patient monitoring devices, sensors, remote monitoring solutions, hospital automation products, and luxury audio sound systems.

What makes Masimo's products unique?

Masimo's products are known for their innovative, noninvasive technology that provides accurate patient monitoring and critical information for clinical decision-making.

Who uses Masimo's healthcare products?

Masimo's healthcare products are used by healthcare professionals in hospitals, clinics, emergency rooms, and other medical settings.

What recent achievements has Masimo Corporation accomplished?

Masimo has expanded their product portfolio with advanced remote monitoring solutions and established partnerships with leading healthcare organizations.

What is the financial status of Masimo Corporation?

Masimo Corporation has shown consistent financial growth and maintains a strong market presence.

What is Masimo's mission?

Masimo's mission is to save, extend, and improve lives by developing innovative medical technologies and solutions.

Where can I find the latest news about Masimo Corporation?

The latest news about Masimo Corporation can be found on their official website and trusted financial news sources.

Masimo Corporation

Nasdaq:MASI

MASI Rankings

MASI Stock Data

9.12B
49.16M
8.19%
94.77%
6.24%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
IRVINE